Edition:
United Kingdom

Dermira Inc (DERM.OQ)

DERM.OQ on NASDAQ Stock Exchange Global Select Market

9.61USD
25 Jun 2019
Change (% chg)

$0.10 (+1.05%)
Prev Close
$9.51
Open
$10.50
Day's High
$10.60
Day's Low
$9.47
Volume
284,957
Avg. Vol
424,549
52-wk High
$15.47
52-wk Low
$6.00

About

Dermira, Inc. is a biopharmaceutical company. The Company is focused on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis, psoriasis and acne. Its portfolio includes three late-stage product candidates: Cimzia (certolizumab pegol), glycopyrronium tosylate and... (more)

Overall

Beta: 1.34
Market Cap(Mil.): $510.38
Shares Outstanding(Mil.): 53.67
Dividend: --
Yield (%): --

Financials

  DERM.OQ Industry Sector
P/E (TTM): -- 105.08 37.43
EPS (TTM): -5.34 -- --
ROI: -56.20 7.78 12.14
ROE: -224.35 8.33 17.05

BRIEF-Dermira Inc Entered Into First Amendment To License Agreement With Roche

* DERMIRA INC - ENTERED INTO FIRST AMENDMENT TO LICENSE AGREEMENT WITH ROCHE

28 Feb 2019

Earnings vs. Estimates